AI Article Synopsis

  • Embryonic-type neuroectodermal tumor (ENT) is a type of cancer involving the overgrowth of embryonic neuroectodermal tissue, making diagnosis difficult due to its mix with other tumor components.
  • This study focused on the immunohistochemical characteristics of ENT, embryonic-type neuroectodermal tissue (EtNT), and mature neuro-glial tissue (MNGT) to enhance diagnostic accuracy.
  • The researchers found SOX2 to be the most effective marker for EtNT and suggested a combination of various markers (including SOX11, GFAP, and others) to better identify and quantify EtNT in germ cell tumors.

Article Abstract

Embryonic-type neuroectodermal tumor (ENT) is a somatic-type malignancy characterized by overgrowth of embryonic-type neuroectodermal tissue (EtNT). In germ cell tumors, EtNT is frequently intermingled with other components that may exhibit significant morphologic overlap [mature neuro-glial tissue (MNGT), nephroblastomatous tissues, and primitive endodermal-type glands]. Therefore, the quantification of EtNT (crucial for the diagnosis of ENT) can be challenging. In this study, we investigated the immunohistochemical profile of ENT, EtNT, and MNGT using a broad immunohistochemical panel. We found that SOX2 was the most sensitive marker for EtNT (100%), but it also stained MNGT (28.6%). GFAP and S100 were relatively sensitive (71.4%) and highly specific (GFAP 100%, S100 85.8%) for MNGT, whereas synaptophysin stained both. Combining our results with those of previous studies, we propose that a combination of SOX11, SOX2, GFAP, S100, AFP, villin, CDX2, PAX8, and nuclear WT1 may help to identify and quantify EtNT in germ cell tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-024-03911-8DOI Listing

Publication Analysis

Top Keywords

embryonic-type neuroectodermal
16
neuroectodermal tumor
8
neuroectodermal tissue
8
neuro-glial tissue
8
broad immunohistochemical
8
immunohistochemical panel
8
etnt germ
8
germ cell
8
cell tumors
8
gfap s100
8

Similar Publications

Embryonic-type neuroectodermal tumors (ENTs) arising from testicular germ cell tumors (GCTs) is a relatively common type of somatic transformation in GCTs with poor prognosis and limited therapeutic options, particularly when patients develop disease recurrence or metastasis. Knowledge of key events driving this transformation is limited to the paucity of comprehensive genomic data. We performed a retrospective database search in a CLIA- and CAP-certified laboratory for testicular GCT-derived ENTs that had previously undergone NGS-based comprehensive genomic profiling during the course of clinical care.

View Article and Find Full Text PDF
Article Synopsis
  • Embryonic-type neuroectodermal tumor (ENT) is a type of cancer involving the overgrowth of embryonic neuroectodermal tissue, making diagnosis difficult due to its mix with other tumor components.
  • This study focused on the immunohistochemical characteristics of ENT, embryonic-type neuroectodermal tissue (EtNT), and mature neuro-glial tissue (MNGT) to enhance diagnostic accuracy.
  • The researchers found SOX2 to be the most effective marker for EtNT and suggested a combination of various markers (including SOX11, GFAP, and others) to better identify and quantify EtNT in germ cell tumors.
View Article and Find Full Text PDF

Embryonic-type neuroectodermal elements are often intimately mixed with primitive endodermal-type glands, like those of yolk sac tumors, in germ cell neoplasia in situ (GCNIS)-derived germ cell tumors of the testis. Because the primitive glands mimic tubules or rosettes of embryonic-type neuroectodermal elements, these embryonic-type neuroectodermal/glandular complexes may be misinterpreted as pure lesions of embryonic-type neuroectodermal elements, which, if of sufficient size, may lead to a diagnosis of embryonic-type neuroectodermal tumor, despite that the criteria of the World Health Organization for a "somatic-type malignancy" are not met. A diagnosis of embryonic-type neuroectodermal tumor in the testis may lead to retroperitoneal lymphadenectomy even in clinical stage I patients, and in postchemotherapy resections indicates a poor prognosis.

View Article and Find Full Text PDF
Article Synopsis
  • - Testicular teratomas can appear in both children and adult men, but prognosis varies significantly, with pediatric teratomas usually being benign and occurring mostly before age 4, while adult teratomas often form part of mixed germ cell tumors with higher risk for metastasis.
  • - In rare cases, testicular teratomas can transform into malignant tumors, such as primitive neuroectodermal tumors, which are aggressive and can spread to various locations like the retroperitoneum.
  • - A specific case is highlighted where a patient experienced malignant transformation of a teratoma, leading to metastasis in the mediastinum, and was treated with a combination of surgery and a chemotherapy regimen known as VAC/IE.
View Article and Find Full Text PDF

The development of somatic-type malignancy (SM) in testicular germ cell tumor represents a major challenge in the diagnosis and treatment of testicular cancer. Most SMs are derived from teratoma, and the remainder is associated with yolk sac tumor. They occur more frequently in metastases than in primary testicular tumors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!